A modular, fully customisable real-world evidence (RWE) playbook and hands-on training program to help rare disease teams build internal capability and translate real-world data (RWD) into decision-ready evidence strategy.
Rare disease commercialization demands evidence that is often difficult to generate through traditional clinical development alone. Regulators, payers, HTA bodies, and other access stakeholders still expect robust evidence, including comparative effectiveness, patient relevant outcomes, durability, safety, and economic impact, despite small populations and limited data.
RWD can help close these evidence gaps, but only when used with a fit for purpose strategy that anticipates methodological, operational, and stakeholder challenges.
In response, Lumanity’s comprehensive RWE Playbook and training program is designed to build internal capability and turn knowledge gaps into confident, strategic decision-making.
Speak to an expert at Lumanity to learn more about the RWE Playbook. Email Mateo Delclaux at Mateo.Delclaux@lumanity.com or contact@lumanity.com to discuss your research needs.
Access our playbook synopsis
Complete the form to download our two-pager on the RWE playbook
"*" indicates required fields
